9:41 PM
 | 
Jun 18, 2007
 |  BC Extra  |  Clinical News

Novelos presents ovarian cancer data

NVLT said interim data from 10 evaluable patients in an open-label Phase II trial showed that NOV-002...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >